|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.050 USD | +1.80% |
|
+1.91% | -60.26% |
| 07-08 | Quoin Pharmaceuticals & CFO Gordon Dunn agree to a mutual separation | RE |
| 07-08 | Quoin Pharmaceuticals Ltd. Announces Mutual Separation with CFO Gordon Dunn | CI |
EPS & Dividend: Quoin Pharmaceuticals, Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -28,455 | -1,638 | -337.4 | -66.85 | -27.3 | -15.75 | -2.45 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 9,555.015 | 596.401 | 171.675 | 22.775 | 8.890 | 8.890 | 8.890 |
| Nbr of stocks (in thousands) | 1.59 | 11.5 | 28.2 | 234 | 588.2 | - | - |
| Announcement Date | 14/04/22 | 09/03/23 | 13/03/24 | 13/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Quoin Pharmaceuticals, Ltd.
| 13/08/2025 | Q2 2025 Earnings Release (Projected) |
| 05/11/2025 | Q3 2025 Earnings Release (Projected) |
| 11/03/2026 | Q4 2025 Earnings Release (Projected) |
| 12/05/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| - | - | -0.33x | - | - | ||
| 0.87% | 1.01% | 39.05x | 4.05x | 5.68x | ||
| -.--% | -.--% | 156.36x | 7.36x | 5.39x | ||
| 0.4% | 0.38% | 46.55x | 2.23x | 9.41x | ||
| -.--% | -.--% | 21.78x | 4.24x | 2.53x | ||
| 1.09% | 1.21% | 23.83x | 2.1x | 1.96x | ||
| -.--% | -.--% | 16.11x | 1.21x | 1.83x | ||
| -.--% | -.--% | -42.19x | -58.39x | 14.87x | ||
| 0.1% | 0.1% | 25.41x | 2.8x | 5.24x | ||
| -.--% | -.--% | -37.48x | 38.17x | 8.35x | ||
| Average | 0.27% | 0.3% | 24.91x | 0.42x | 6.14x | |
| Weighted average by Cap. | 0.36% | 0.41% | 44.17x | 2.25x | 5.86x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition